Antagonism between tamoxifen and doxorubicin in the MCF-7 human breast tumor cell line
- 1 April 1994
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 47 (8) , 1449-1452
- https://doi.org/10.1016/0006-2952(94)90346-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Endocrine Pharmacology of Antiestrogens as Antitumor Agents*Endocrine Reviews, 1990
- Modulation of induced resistance to adriamycin in two human breast cancer cell lines with tamoxifen or perhexiline maleateCancer Chemotherapy and Pharmacology, 1988
- Metabolism of adriamycin in hepatocytes isolated from the rat and the rabbitBiochemical Pharmacology, 1987
- Metabolism of the anthracycline antibiotic daunorubicin to daunorubicinol and deoxydaunorubicinol aglycone in hepatocytes isolated from the rat and the rabbitBiochemical Pharmacology, 1986
- Stability of solutions of antineoplastic agents during preparation and storage for in vitro assaysCancer Chemotherapy and Pharmacology, 1986
- Tamoxifen-citrate counteracts the antitumor effects of cytotoxic drugs in vitro.Journal of Clinical Oncology, 1985
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Generalized Equations for the Analysis of Inhibitions of Michaelis-Menten and Higher-Order Kinetic Systems with Two or More Mutually Exclusive and Nonexclusive InhibitorsEuropean Journal of Biochemistry, 1981
- Cancer of the BreastNew England Journal of Medicine, 1980